{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T23:31:05Z","timestamp":1787095865391,"version":"build-2736575974"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.phrs.2021.105572","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T18:46:09Z","timestamp":1616265969000},"page":"105572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":114,"special_numbering":"C","title":["Celastrol in metabolic diseases: Progress and application prospects"],"prefix":"10.1016","volume":"167","author":[{"given":"Shaohua","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqian","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weishen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2021.105572_bib1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.drudis.2015.01.009","article-title":"An analysis of FDA-approved drugs: natural products and their derivatives","volume":"21","author":"Patridge","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.phrs.2021.105572_bib2","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/med.21751","article-title":"Biosynthesis, total synthesis, structural modifications, bioactivity, and mechanism of action of the quinone-methide triterpenoid celastrol","volume":"41","author":"Lu","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.phrs.2021.105572_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.chroma.2003.11.072","article-title":"Preparative isolation and purification of celastrol from Celastrus orbiculatus Thunb. by a new counter-current chromatography method with an upright coil planet centrifuge","volume":"1028","author":"Wu","year":"2004","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.phrs.2021.105572_bib4","doi-asserted-by":"crossref","unstructured":"Y. Zhang, X. Mao, W. Li, W. Chen, X. Wang, Z. Ma, N. Lin, Tripterygium wilfordii: An inspiring resource for rheumatoid arthritis treatment, Medicinal Research Reviews (Online version). https:\/\/doi.org\/10.1002\/med.21762.","DOI":"10.1002\/med.21762"},{"key":"10.1016\/j.phrs.2021.105572_bib5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.critrevonc.2018.05.019","article-title":"Molecular targets of celastrol in cancer: Recent trends and advancements","volume":"128","author":"Dharambir","year":"2018","journal-title":"Crit. Rev. Oncol.\/hematol."},{"key":"10.1016\/j.phrs.2021.105572_bib6","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cell.2007.08.021","article-title":"Molecular understanding and modern application of traditional medicines: triumphs and trials","volume":"130","author":"Corson","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2021.105572_bib7","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/iub.1563","article-title":"The progress and challenges in metabolic research in China","volume":"68","author":"Xu","year":"2016","journal-title":"IUBMB Life"},{"key":"10.1016\/j.phrs.2021.105572_bib8","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.cell.2015.05.011","article-title":"Treatment of obesity with celastrol","volume":"161","author":"Liu","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2021.105572_bib9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11426-018-9404-9","article-title":"Celastrol as a tool for the study of the biological events of metabolic diseases","volume":"62","author":"Lan","year":"2019","journal-title":"Sci. China Chem."},{"key":"10.1016\/j.phrs.2021.105572_bib10","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.biopha.2018.11.051","article-title":"Molecular modulators of celastrol as the keystones for its diverse pharmacological activities","volume":"109","author":"Ng","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2021.105572_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2017.00069","article-title":"Celastrol: a spectrum of treatment opportunities in chronic diseases","volume":"4","author":"Cascao","year":"2017","journal-title":"Front. Med."},{"key":"10.1016\/j.phrs.2021.105572_bib12","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(05)67483-1","article-title":"Obesity","volume":"366","author":"Haslam","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2021.105572_bib13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuroscience.2020.08.009","article-title":"Reprint of: recent updates on obesity treatments: available drugs and future directions","volume":"447","author":"Dragano","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2021.105572_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2020.112513","article-title":"Mechanisms of action for the anti-obesogenic activities of phytochemicals","volume":"180","author":"Ahmad","year":"2020","journal-title":"Phytochemistry"},{"key":"10.1016\/j.phrs.2021.105572_bib15","article-title":"Celastrol, an NF-\u03baB inhibitor, improves insulin resistance and attenuates renal injury in db\/db mice","volume":"8","author":"Kim","year":"2013","journal-title":"Plos One"},{"key":"10.1016\/j.phrs.2021.105572_bib16","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/s42255-019-0095-y","article-title":"Leptin and the endocrine control of energy balance","volume":"1","author":"Friedman","year":"2019","journal-title":"Nat. Metab."},{"key":"10.1016\/j.phrs.2021.105572_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.metabol.2014.10.015","article-title":"Leptin resistance and diet-induced obesity: central and peripheral actions of leptin","volume":"64","author":"S\u00e1inz","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.phrs.2021.105572_bib18","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41591-019-0358-x","article-title":"IL1R1 is required for celastrol\u2019s leptin-sensitization and antiobesity effects","volume":"25","author":"Feng","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2021.105572_bib19","doi-asserted-by":"crossref","first-page":"12809","DOI":"10.1038\/s41598-019-49151-8","article-title":"Lipocalin 2 does not play a role in celastrol-mediated reduction in food intake and body weight","volume":"9","author":"Feng","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2021.105572_bib20","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2337\/db18-1167","article-title":"Celastrol reduces obesity in MC4R deficiency and stimulates sympathetic nerve activity affecting metabolic and cardiovascular functions","volume":"68","author":"Saito","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2021.105572_bib21","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.2337\/db18-0146","article-title":"Celastrol-induced weight loss is driven by hypophagia and independent from UCP1","volume":"67","author":"Pfuhlmann","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2021.105572_bib22","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.cmet.2011.09.011","article-title":"Elevated hypothalamic TCPTP in obesity contributes to cellular leptin resistance","volume":"14","author":"Loh","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2021.105572_bib23","doi-asserted-by":"crossref","first-page":"11144","DOI":"10.1021\/acs.jmedchem.8b01224","article-title":"Celastrol promotes weight loss in diet-induced obesity by inhibiting the protein tyrosine phosphatases PTP1B and TCPTP in the hypothalamus","volume":"61","author":"Kyriakou","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2021.105572_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12874","article-title":"The leptin sensitizer celastrol reduces age-associated obesity and modulates behavioral rhythms","volume":"18","author":"Chellappa","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.phrs.2021.105572_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104713","article-title":"Detection and quantification of the anti-obesity drug celastrol in murine liver and brain","volume":"136","author":"De Angelis","year":"2020","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.phrs.2021.105572_bib26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.peptides.2012.05.016","article-title":"Galanin and its receptors: a novel strategy for appetite control and obesity therapy","volume":"36","author":"Fang","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.phrs.2021.105572_bib27","first-page":"1341","article-title":"Treatment with celastrol protects against obesity through suppression of galanin-induced fat intake and activation of PGC-1a\/GLUT4 axis-mediated glucose consumption","volume":"2019","author":"Fang","year":"1865","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.phrs.2021.105572_bib28","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/CIRCULATIONAHA.111.087213","article-title":"Energy balance and obesity","volume":"126","author":"Hill","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2021.105572_bib29","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.cmet.2015.08.005","article-title":"Celastrol protects against obesity and metabolic dysfunction through activation of a HSF1-PGC1 alpha transcriptional axis","volume":"22","author":"Ma","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2021.105572_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173371","article-title":"Celastrol attenuates inflammatory responses in adipose tissues and improves skeletal muscle mitochondrial functions in high fat diet-induced obese rats via upregulation of AMPK\/SIRT1 signaling pathways","volume":"883","author":"Abu Bakar","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105572_bib31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ptr.6800","article-title":"Celastrol alleviates metabolic disturbance in high-fat diet-induced obese mice through increasing energy expenditure by ameliorating metabolic inflammation","volume":"35","author":"Yang","year":"2020","journal-title":"Phytother. Res."},{"key":"10.1016\/j.phrs.2021.105572_bib32","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1152\/ajpregu.00045.2016","article-title":"The role of leptin in energy expenditure: the hypothalamic perspective","volume":"312","author":"Pandit","year":"2017","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.phrs.2021.105572_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.molcel.2017.03.008","article-title":"Celastrol-induced Nur77 interaction with TRAF2 alleviates inflammation by promoting mitochondrial ubiquitination and autophagy","volume":"66","author":"Hu","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2021.105572_bib34","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1210\/me.2010-0015","article-title":"Minireview: nuclear hormone receptor 4A signaling: implications for metabolic disease","volume":"24","author":"Pearen","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.phrs.2021.105572_bib35","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.2337\/db14-1206","article-title":"Enhancement of hypothalamic STAT3 acetylation by nuclear receptor Nur77 dictates leptin sensitivity","volume":"64","author":"Chen","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2021.105572_bib36","first-page":"2068","article-title":"Natural product celastrol suppressed macrophage M1 polarization against inflammation in diet-induced obese mice via regulating Nrf2\/HO-1, MAP kinase and NF-\u03baB pathways","volume":"9","author":"Luo","year":"2017","journal-title":"Aging US"},{"key":"10.1016\/j.phrs.2021.105572_bib37","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejphar.2014.09.043","article-title":"Celastrol suppresses obesity process via increasing antioxidant capacity and improving lipid metabolism","volume":"744","author":"Wang","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105572_bib38","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1021\/acs.jproteome.8b00797","article-title":"Modulation of lipid metabolism by celastrol","volume":"18","author":"Zhang","year":"2019","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.phrs.2021.105572_bib39","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.metabol.2016.01.009","article-title":"Cascade regulation of PPAR\u03b32 and C\/EBP\u03b1 signaling pathways by celastrol impairs adipocyte differentiation and stimulates lipolysis in 3T3-L1 adipocytes","volume":"65","author":"Choi","year":"2016","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.phrs.2021.105572_bib40","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bbrc.2018.11.014","article-title":"Inhibitory effect of celastrol on adipogenic differentiation of human adipose-derived stem cells","volume":"507","author":"Hong","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2021.105572_bib41","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1053\/j.gastro.2016.12.048","article-title":"Role of the gut microbiome in the pathogenesis of obesity and obesity-related metabolic dysfunction","volume":"152","author":"Bouter","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2021.105572_bib42","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4093\/dmj.2019.0124","article-title":"Effects of microbiota on the treatment of obesity with the natural product celastrol in rats","volume":"44","author":"Hu","year":"2020","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.phrs.2021.105572_bib43","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1210\/en.2012-2151","article-title":"The gut microbiota reduces leptin sensitivity and the expression of the obesity-suppressing neuropeptides proglucagon (Gcg) and brain-derived neurotrophic factor (Bdnf) in the central nervous system","volume":"154","author":"Erik","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.phrs.2021.105572_bib44","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/qjmed\/hcx152","article-title":"Complications of obesity","volume":"111","author":"Kinlen","year":"2018","journal-title":"QJM Int. J. Med."},{"key":"10.1016\/j.phrs.2021.105572_bib45","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41420-019-0196-0","article-title":"Celastrol attenuates ox-LDL-induced mesangial cell proliferation via suppressing NLRP3 inflammasome activation","volume":"5","author":"Sun","year":"2019","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.phrs.2021.105572_bib46","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.molmet.2016.11.002","article-title":"Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1","volume":"6","author":"Zhang","year":"2017","journal-title":"Mol. Metab."},{"key":"10.1016\/j.phrs.2021.105572_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00049","article-title":"Celastrol alleviates airway hyperresponsiveness and inhibits Th17 responses in obese asthmatic mice","volume":"9","author":"Zeng","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105572_bib48","article-title":"Enhanced inflammatory reaction and thrombosis in high-fat diet-fed ApoE-\/- mice are attenuated by celastrol","author":"Ouyang","year":"2020","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.phrs.2021.105572_bib49","first-page":"1","article-title":"Introduction to diabetes mellitus","volume":"771","author":"Kaul","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.phrs.2021.105572_bib50","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.2147\/DMSO.S275898","article-title":"Obesity, insulin resistance, and type 2 diabetes: associations and therapeutic implications","volume":"13","author":"Tsegyie","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes. Targets Ther."},{"key":"10.1016\/j.phrs.2021.105572_bib51","doi-asserted-by":"crossref","first-page":"S307","DOI":"10.1016\/j.dsx.2017.03.006","article-title":"Signaling pathways linking inflammation to insulin resistance","volume":"11","author":"Zand","year":"2017","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"10.1016\/j.phrs.2021.105572_bib52","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.intimp.2016.08.026","article-title":"Potential therapeutic targets for inflammation in toll-like receptor 4 (TLR4)-mediated signaling pathways","volume":"40","author":"Roy","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2021.105572_bib53","doi-asserted-by":"crossref","first-page":"13997","DOI":"10.1038\/ncomms13997","article-title":"Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2","volume":"8","author":"Wang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2021.105572_bib54","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jep.2015.06.028","article-title":"Celastrol blocks binding of lipopolysaccharides to a Toll-like receptor4\/myeloid differentiation factor2 complex in a thiol-dependent manner","volume":"172","author":"Lee","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2021.105572_bib55","doi-asserted-by":"crossref","first-page":"6814","DOI":"10.1002\/jcp.26547","article-title":"Celastrol reverses palmitic acid (PA)-caused TLR4-MD2 activation-dependent insulin resistance via disrupting MD2-related cellular binding to PA","volume":"233","author":"Zhang","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.phrs.2021.105572_bib56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2017.01.043","article-title":"Celastrol attenuates mitochondrial dysfunction and inflammation in palmitate-mediated insulin resistance in C3A hepatocytes","volume":"799","author":"Abu Bakar","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105572_bib57","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.biopha.2017.07.021","article-title":"Improvement of mitochondrial function by celastrol in palmitate-treated C2C12 myotubes via activation of PI3K-Akt signaling pathway","volume":"93","author":"Abu Bakar","year":"2017","journal-title":"Biomed.\u00a0Pharmacother."},{"key":"10.1016\/j.phrs.2021.105572_bib58","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jcjd.2018.07.002","article-title":"Celastrol reverses palmitic acid-induced insulin resistance in HepG2 cells via restoring the miR-223 and GLUT4 pathway","volume":"43","author":"Zhang","year":"2019","journal-title":"Can. J. Diabetes"},{"key":"10.1016\/j.phrs.2021.105572_bib59","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1053\/j.ajkd.2018.06.033","article-title":"Diabetic kidney disease: the tiger may have new stripes","volume":"72","author":"Umanath","year":"2018","journal-title":"Am. J. Kidney Dis. Off. J. Nat. Kidney Found."},{"key":"10.1016\/j.phrs.2021.105572_bib60","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.molimm.2018.10.021","article-title":"Celastrol antagonizes high glucose-evoked podocyte injury, inflammation and insulin resistance by restoring the HO-1-mediated autophagy pathway","volume":"104","author":"Zhan","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.phrs.2021.105572_bib61","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/ptr.6314","article-title":"Celastrol attenuates renal injury in diabetic rats via MAPK\/NF-\u03baB pathway","volume":"33","author":"Zhang","year":"2019","journal-title":"Phytother. Res."},{"key":"10.1016\/j.phrs.2021.105572_bib62","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12906-020-03050-y","article-title":"Celastrol slows the progression of early diabetic nephropathy in rats via the PI3K\/AKT pathway","volume":"20","author":"Nie","year":"2020","journal-title":"BMC Complement. Med. Ther."},{"key":"10.1016\/j.phrs.2021.105572_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/2641248","article-title":"Protective effects of celastrol on diabetic liver injury via TLR4\/MyD88\/NF-\u03baB signaling pathway in type 2 diabetic rats","volume":"2016","author":"Han","year":"2016","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.phrs.2021.105572_bib64","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.3892\/ijmm.2016.2549","article-title":"Celastrol attenuates oxidative stress in the skeletal muscle of diabetic rats by regulating the AMPK-PGC1 alpha-SIRT3 signaling pathway","volume":"37","author":"Guan","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.phrs.2021.105572_bib65","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1002\/fsn3.1917","article-title":"Protective effect of celastrol on type 2 diabetes mellitus with nonalcoholic fatty liver disease in mice","volume":"8","author":"Sun","year":"2020","journal-title":"Food Sci. Nutr."},{"key":"10.1016\/j.phrs.2021.105572_bib66","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","article-title":"Mechanisms linking obesity to insulin resistance and type 2 diabetes","volume":"444","author":"Kahn","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2021.105572_bib67","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/00003495-199958001-00015","article-title":"Prevention of type 2 diabetes: role of metformin","volume":"58","author":"Charles","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.phrs.2021.105572_bib68","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1185\/030079901750120231","article-title":"Comparison of acarbose and gliclazide as first-line agents in patients with type 2 diabetes","volume":"16","author":"Salman","year":"2001","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.phrs.2021.105572_bib69","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2021.105572_bib70","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.5897\/AJPP11.458","article-title":"Celastrol attenuates atherosclerosis in Apolipoprotein E (apoE) knockout mice fed an atherogenic diet","volume":"5","author":"Cheng","year":"2011","journal-title":"Afr. J. Pharm. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105572_bib71","article-title":"Celastrol prevents atherosclerosis via inhibiting LOX-1 and oxidative stress","volume":"8","author":"Gu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2021.105572_bib72","first-page":"1684","article-title":"Celastrol may have an anti-atherosclerosis effect in a rabbit experimental carotid atherosclerosis model","volume":"7","author":"Zhu","year":"2014","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.phrs.2021.105572_bib73","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"118","author":"Bennett","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2021.105572_bib74","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/jcb.24374","article-title":"Celastrol attenuates adipokine resistin-associated matrix interaction and migration of vascular smooth muscle cells","volume":"114","author":"Kang","year":"2013","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.phrs.2021.105572_bib75","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.3892\/mmr.2017.7533","article-title":"Celastrol alleviates angiotensin II-mediated vascular smooth muscle cell senescence via induction of autophagy","volume":"16","author":"Xu","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.phrs.2021.105572_bib76","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.bbrc.2020.08.076","article-title":"Celastrol suppresses lipid accumulation through LXR alpha\/ABCA1 signaling pathway and autophagy in vascular smooth muscle cells","volume":"532","author":"Shi","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2021.105572_bib77","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.2741\/4172","article-title":"Endothelial progenitor cells and atherosclerosis","volume":"18","author":"Ruan","year":"2013","journal-title":"Front. Biosci."},{"key":"10.1016\/j.phrs.2021.105572_bib78","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1159\/000430234","article-title":"Tripterine treatment improves endothelial progenitor cell function via integrin-linked kinase","volume":"37","author":"Lu","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.phrs.2021.105572_bib79","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/jcp.24849","article-title":"Short time tripterine treatment enhances endothelial progenitor cell function via heat shock protein 32","volume":"230","author":"Lu","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.phrs.2021.105572_bib80","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/hep.27744","article-title":"Fibrates and cholestasis","volume":"62","author":"Ghonem","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2021.105572_bib81","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1074\/mcp.RA118.000817","article-title":"Celastrol protects from cholestatic liver injury through modulation of SIRT1-FXR signaling","volume":"18","author":"Zhao","year":"2019","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.phrs.2021.105572_bib82","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5604\/01.3001.0012.7860","article-title":"Celastrol attenuates intrahepatic cholestasis of pregnancy by inhibiting matrix metalloproteinases-2 and 9","volume":"18","author":"Guo","year":"2019","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.phrs.2021.105572_bib83","doi-asserted-by":"crossref","first-page":"16887","DOI":"10.18632\/aging.103590","article-title":"Celastrol regulates bone marrow mesenchymal stem cell fate and bone-fat balance in osteoporosis and skeletal aging by inducing PGC-1 alpha signaling","volume":"12","author":"Li","year":"2020","journal-title":"Aging US"},{"key":"10.1016\/j.phrs.2021.105572_bib84","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.cell.2015.05.023","article-title":"Advancing biological understanding and therapeutics discovery with small-molecule probes","volume":"161","author":"Schreiber","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2021.105572_bib85","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1039\/C6MB00691D","article-title":"Competitive profiling of celastrol targets in human cervical cancer HeLa cells via quantitative chemical proteomics","volume":"13","author":"Zhou","year":"2017","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.phrs.2021.105572_bib86","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/CIRCRESAHA.119.315861","article-title":"Celastrol attenuates angiotensin II-induced cardiac remodeling by targeting STAT3","volume":"126","author":"Ye","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2021.105572_bib87","doi-asserted-by":"crossref","first-page":"10290","DOI":"10.7150\/thno.46728","article-title":"Celastrol induces ROS-mediated apoptosis via directly targeting peroxiredoxin-2 in gastric cancer cells","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.phrs.2021.105572_bib88","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijpharm.2014.06.019","article-title":"Solid self-microemulsifying dispersible tablets of celastrol: formulation development, charaterization and bioavailability evaluation","volume":"472","author":"Qi","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.phrs.2021.105572_bib89","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jep.2012.09.005","article-title":"Oral bioavailability and gender-related pharmacokinetics of celastrol following administration of pure celastrol and its related tablets in rats","volume":"144","author":"Zhang","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2021.105572_bib90","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2017-eular.2868","article-title":"Efficacy and safety of oral administration of pure celastrol in aia rats","volume":"76","author":"Cascao","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2021.105572_bib91","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12640-014-9477-9","article-title":"Lack of neuroprotective effect of celastrol under conditions of proteasome inhibition by lactacystin in in vitro and in vivo studies: implications for Parkinson\u2019s disease","volume":"26","author":"Konieczny","year":"2014","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.phrs.2021.105572_bib92","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0014-2999(03)01351-7","article-title":"Effects of demethylzeylasteral and celastrol on spermatogenic cell Ca2+ channels and progesterone-induced sperm acrosome reaction","volume":"464","author":"Bai","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105572_bib93","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.3390\/molecules24112162","article-title":"CYP450s-activity relations of celastrol to interact with triptolide reveal the reasons of hepatotoxicity of Tripterygium wilfordii","volume":"24","author":"Jin","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2021.105572_bib94","first-page":"2078","article-title":"Celastrol aggravates LPS-induced inflammation and injuries of liver and kidney in mice","volume":"10","author":"Wu","year":"2018","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.phrs.2021.105572_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035733","article-title":"Development of B cells and erythrocytes is specifically impaired by the drug celastrol in mice","volume":"7","author":"Kusy","year":"2012","journal-title":"Plos One"},{"key":"10.1016\/j.phrs.2021.105572_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2019.114785","article-title":"Integrated metabolomics and network toxicology to reveal molecular mechanism of celastrol induced cardiotoxicity","volume":"383","author":"Liu","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105572_bib97","first-page":"634","article-title":"Preliminary study on cardiotoxicity of celastrol to zebrafish embryo","volume":"25","author":"Wang","year":"2009","journal-title":"Chin. Pharmacol. Bull."},{"key":"10.1016\/j.phrs.2021.105572_bib98","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/01480545.2010.494664","article-title":"Toxic effects of celastrol on embryonic development of zebrafish (Danio rerio)","volume":"34","author":"Wang","year":"2011","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.phrs.2021.105572_bib99","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jconrel.2019.08.026","article-title":"Celastrol-loaded PEG-PCL nanomicelles ameliorate inflammation, lipid accumulation, insulin resistance and gastrointestinal injury in diet-induced obese mice","volume":"310","author":"Zhao","year":"2019","journal-title":"J. Controll. Release"},{"key":"10.1016\/j.phrs.2021.105572_bib100","first-page":"6055","article-title":"Natural product-based nanomedicine: recent advances and issues","volume":"10","author":"Bin","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.phrs.2021.105572_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.558741","article-title":"Celastrol: a review of useful strategies overcoming its limitation in anticancer application","volume":"11","author":"Shi","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105572_bib102","doi-asserted-by":"crossref","first-page":"10954","DOI":"10.1039\/D0TB01939A","article-title":"Current advances in the nano-delivery of celastrol for treating inflammation-associated diseases","volume":"8","author":"Fang","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.phrs.2021.105572_bib103","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1039\/C8BM01224E","article-title":"Celastrol-loaded PEG-b-PPS nanocarriers as an anti-inflammatory treatment for atherosclerosis","volume":"7","author":"Allen","year":"2019","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.phrs.2021.105572_bib104","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1073\/pnas.0712365105","article-title":"Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia","volume":"105","author":"Wang","year":"2008","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2021.105572_bib105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000449084","article-title":"Promises and dangers of combination therapy","volume":"35","author":"Kruis","year":"2017","journal-title":"Dig. Dis."},{"key":"10.1016\/j.phrs.2021.105572_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112081","article-title":"Celastrol: progresses in structure-modifications, structure-activity relationships, pharmacology and toxicology","volume":"189","author":"Hou","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phrs.2021.105572_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2019.104190","article-title":"The genus Tripterygium: a phytochemistry and pharmacological review","volume":"137","author":"Lv","year":"2019","journal-title":"Fitoterapia"},{"key":"10.1016\/j.phrs.2021.105572_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.111934","article-title":"Traditional uses, secondary metabolites, and pharmacology of Celastrus species - a review","volume":"241","author":"Shen","year":"2019","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2021.105572_bib109","doi-asserted-by":"crossref","first-page":"11864","DOI":"10.1021\/jacs.5b06261","article-title":"Total synthesis of celastrol, development of a platform to access celastroid natural products","volume":"137","author":"Camelio","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.phrs.2021.105572_bib110","article-title":"Establishment of adventitious root cultures from leaf explants of Tripterygium wilfordii (thunder god vine) for the production of celastrol","volume":"155","author":"Zhang","year":"2020","journal-title":"Ind. Crops\u00a0Prod."},{"key":"10.1016\/j.phrs.2021.105572_bib111","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13007-019-0513-x","article-title":"A novel strategy to enhance terpenoids production using cambial meristematic cells of Tripterygium wilfordii Hook. f","volume":"15","author":"Song","year":"2019","journal-title":"Plant Methods"},{"key":"10.1016\/j.phrs.2021.105572_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.bej.2020.107681","article-title":"Enhanced production of celastrol in Tripterygium wilfordii hairy root cultures by overexpression of TwSQS2","volume":"161","author":"Zhang","year":"2020","journal-title":"Biochem. Eng. J."},{"key":"10.1016\/j.phrs.2021.105572_bib113","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/10286020.2015.1134504","article-title":"The MVA pathway genes expressions and accumulation of celastrol in Tripterygium wilfordii suspension cells in response to methyl jasmonate treatment","volume":"18","author":"Liu","year":"2016","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.phrs.2021.105572_bib114","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12934-020-1284-9","article-title":"Integrating pathway elucidation with yeast engineering to produce polpunonic acid the precursor of the anti-obesity agent celastrol","volume":"19","author":"Hansen","year":"2020","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.phrs.2021.105572_bib115","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1093\/pcp\/pcz144","article-title":"CYP712K4 catalyzes the C-29 oxidation of friedelin in the Maytenus ilicifolia quinone methide triterpenoid biosynthesis pathway","volume":"60","author":"Bicalho","year":"2019","journal-title":"Plant Cell Physiol."},{"key":"10.1016\/j.phrs.2021.105572_bib116","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/nph.15809","article-title":"Friedelane-type triterpene cyclase in celastrol biosynthesis from Tripterygium wilfordii and its application for triterpenes biosynthesis in yeast","volume":"223","author":"Zhou","year":"2019","journal-title":"New Phytol."},{"key":"10.1016\/j.phrs.2021.105572_bib117","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1182\/blood-2006-10-050807","article-title":"Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-\u03baB\u2013regulated gene products and TAK1-mediated NF-\u03baB activation","volume":"109","author":"Sethi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2021.105572_bib118","article-title":"Celastrol inhibits lipopolysaccharide-stimulated rheumatoid fibroblast-like synoviocyte invasion through suppression of TLR4\/NF-\u03baB-mediated matrix metalloproteinase-9 expression","volume":"8","author":"Li","year":"2013","journal-title":"Plos One"},{"key":"10.1016\/j.phrs.2021.105572_bib119","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.phrs.2011.05.027","article-title":"Celastrol regulates innate immunity response via NF-\u03baB and Hsp70 in human retinal pigment epithelial cells","volume":"64","author":"Paimela","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2021.105572_bib120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","article-title":"30 years of NF-\u03baB: a blossoming of relevance to human pathobiology","volume":"168","author":"Zhang","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2021.105572_bib121","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.bcp.2006.08.014","article-title":"Inhibition of NF-\u03baB activation through targeting I\u03baB kinase by celastrol, a quinone methide triterpenoid","volume":"72","author":"Lee","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105572_bib122","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.1002\/anie.200900929","article-title":"Molecular mechanism of inhibition of the human protein complex Hsp90-Cdc37, a kinome chaperone-cochaperone, by triterpene celastrol","volume":"48","author":"Sreeramulu","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.phrs.2021.105572_bib123","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1091\/mbc.e07-10-1004","article-title":"Activation of heat shock and antioxidant responses by the natural product celastrol: transcriptional signatures of a thiol-targeted molecule","volume":"19","author":"Trott","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.phrs.2021.105572_bib124","unstructured":"ERX Pharmaceuticals Inc., ERX-1000 preliminary clinical results, 2021. https:\/\/www.erxpharmaceuticals.com\/research-development\/erx-1000-for-obesity\/. Accessed 6 March 2021."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821001560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821001560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:24:03Z","timestamp":1760912643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661821001560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":124,"alternative-id":["S1043661821001560"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105572","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Celastrol in metabolic diseases: Progress and application prospects","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105572","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105572"}}